NCT04041089

Brief Summary

Posterior cortical atrophy (PCA) is manifested by neuro-visual disorders that alter the spatial location of objects, their manipulation and/or recognition. Its etiology is most often neurodegenerative, with a major impact on the autonomy and mood of patients and their families. Few studies have focused on non-medication management of these disorders. The present study thus has a double objective: the development of a complete tool to work on the recognition, localization and/or manipulation of objects; and the evaluation of the effectiveness of this type of management.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 30, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 1, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

September 2, 2019

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2022

Completed
Last Updated

March 22, 2023

Status Verified

February 1, 2023

Enrollment Period

1.8 years

First QC Date

July 30, 2019

Last Update Submit

March 21, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Effectiveness evaluation

    Effectiveness will be evaluated a score based on success rate (from 0 to 10), reaction time and eye-recording .

    At week 34

Study Arms (3)

Recognition of objects

EXPERIMENTAL

Patients will do the therapy in the following order: object location, object manipulation and object recognition

Behavioral: Recognition of objects

Location of objects

EXPERIMENTAL

Patients will do the therapy in the following order: object recognition, object location, and object manipulation

Behavioral: Location of objects

Manipulation of objects

EXPERIMENTAL

Patients will do the therapy in the following order: object manipulation, object recognition and object location

Behavioral: Manipulation of objects

Interventions

* Name of shapes / colors / images / objects * Classification of shapes / colors / images / objects

Recognition of objects

* Search for frequent/rarse targets among distractors sharing one or more characteristics with the target * Hit/catch a stationary/mobile target as quickly as possible

Location of objects

* Storage of shapes/objects * Use of everyday objects (pen, cutlery, etc.)

Manipulation of objects

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>50 years old
  • Male or Female
  • Patients with a diagnosis of PCA according to the criteria of Tang-Wai et al (2004)
  • MMS\>15
  • Voluntary, written and informed consent of the patient himself or its legal representative (guardian/curator), with oral consent of the patient in all cases
  • Anti-Alzheimer's and psychotropic treatments stable for one month, if taken by the patient
  • Affiliation to a social security system

You may not qualify if:

  • Uncorrected visual disorders with non-degenerative etiology (AV\<0.5)
  • Person under the protection of justice
  • Pregnant women (a pregnancy test will be performed in premenopausal women)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut Claude Pompidou - Centre Mémoire de Ressources et de Recherche du CHU de Nice

Nice, Alpes-Maritime, 06100, France

Location

Study Officials

  • MOUTON Aurélie, Ph

    Centre Hospitalier Universitaire de Nice

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 30, 2019

First Posted

August 1, 2019

Study Start

September 2, 2019

Primary Completion

June 15, 2021

Study Completion

June 15, 2022

Last Updated

March 22, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations